Citicode Ltd. Shareholders Approve Reverse Takeover of Homegrown Multi-Disciplinary Healthcare Specialist Livingstone Health Holdings Limited
SINGAPORE, Jan 22, 2021 - (ACN Newswire) - Shareholders of Citicode Ltd. ( Citicode or the Company ) today approved the reverse takeover ( RTO ) of homegrown multi-disciplinary healthcare specialist Livingstone Health, marking the start of a new chapter of growth in Singapore and across the Asia Pacific region.
At the extraordinary general meeting ( EGM ), shareholders of Citicode approved the RTO and the transfer of the Company s shares from the SGX Mainboard to the Catalist Board and change of corporate identity to Livingstone Health Holdings Limited ( Livingstone Health Holdings ).
Livingstone Health Holdings has 15 medical doctors practising at 12 medical clinics and one medical spa located at various Singapore locations. It offers tertiary healthcare services such as aesthetics and wellness, anaesthesiology and pain management, intern
The Jefferson Parish Sheriff's Office is asking for the public's help locating several people wanted in connection with vehicle burglaries across the parish.
Friday, 22 January 2021 - 11:18
Supporting the health authority's call to minimize physical exposure at any given time to break the vicious circle of the spread of the pandemic, two leading customer services providers will jointly promote their respective businesses digitally without compromising on service quality, effectiveness or deliverables.
CH17 Loyalty has broken all barriers in the loyalty sphere. They have brought in a completely new eco-system to manage and implement different schemes that suites best for buyer as well as the seller. CH17 introduced “One Card Multiple Services” a
concept that fits the customer and the retailer / merchant. Retailers or merchants could join the scheme for Free.
Fujitsu Delivers Cashless, Contactless Retail Experience for Masked Shoppers with Hygienic, Multi-Factor Biometric Authentication Technology
KAWASAKI, Japan, Jan 21, 2021 - (JCN Newswire) - Fujitsu Laboratories, Ltd. has announced the development of a new multi-factor biometric authentication technology to deliver an innovative shopping experience for the New Normal era, combining non-contact biometrics that filter the verification target through facial data with identification performed via palm vein recognition. This technology enables identification with greater than 99% accuracy even when the user wears a mask, and will be showcased at a concept cashless Lawson convenience store at the Fujitsu Technology Square office in Shin-Kawasaki, Japan (1), for a field trial starting from January 2021.